Puma Biotechnology, Inc. (PBYI)

Pharmaceutical Preparations

Latest Price

$10.92

TTM P/E

21.00

Normalized P/E

27.74

TTM Div Yield

Fwd Div Yield

Book Value

2.72

P/B Ratio

4.01

Valuation metrics

EPS: $0.61

Book value / share: $2.59

Formula: √(22.5 × EPS × BVPS)

Graham Number

$5.96

45% downside

Norm. op. income: $24M (median of 7yr)

Tax rate: 9%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$5.77

47% downside

Base FCF: $33M (median of recent 5yr)

Growth: 16%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$26.99

+149% upside

EPS: $0.61

Target P/E: 28×

Formula: EPS × P/E

P/E Fair Value

$17.08

+57% upside

70.2% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
Acorn Capital Advisors, LLC	4.13M	$33.0M	8.08%	--	2026-06-30
BlackRock, Inc.	3.80M	$30.0M	7.45%	+205.8K	2026-06-30
American Century Companies Inc	2.32M	$18.0M	4.54%	+403.6K	2026-06-30
Renaissance Technologies LLC	1.84M	$14.0M	3.59%	-106.2K	2026-06-30
Vanguard Capital Management LLC	1.84M	$14.0M	3.59%	+18.0K	2026-06-30
Vanguard Portfolio Management LLC	1.83M	$14.0M	3.57%	+91.0K	2026-06-30
Lsv Asset Management	1.62M	$13.0M	3.17%	+435.1K	2026-06-30
Dimensional Fund Advisors LP	1.52M	$12.0M	2.97%	+81.9K	2026-06-30
Geode Capital Management, LLC	1.34M	$10.0M	2.62%	+322.1K	2026-06-30
O'shaughnessy Asset Management, LLC	1.12M	$9.0M	2.20%	-14.4K	2026-06-30